Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 128OTHER_GOV 6NIH 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 2Patient Compliance 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 77Paclitaxel 47Trastuzumab 40Tamoxifen 39Doxorubicin 37Docetaxel 35Radiotherapy 32Fluorouracil 26Chemotherapy, Adjuvant 26Taxes 23Epirubicin 22Carboplatin 22Filgrastim 21Specimen Handling 19Methotrexate 19Magnetic Resonance Spectroscopy 19Neoadjuvant Therapy 18aldesleukin 16Peripheral Blood Stem Cell Transplantation 16Bevacizumab 13Lapatinib 12CMF regimen 12Anastrozole 12exemestane 11Goserelin 11Capecitabine 11Biopsy 11veliparib 10sargramostim 10fludarabine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Breast Neoplasms × Exercise × Clear all
NCT00092950 2017-07-02

Exercise in Women at Risk for Breast Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
88 enrolled
Breast

Breast Neoplasms, Motor Activity, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡